Novel Drug Launches in Most-Favored-Nation Countries and Medicare Pricing Benchmarks
Mengyuan Fu, Rohini Ghosh, Erfan Taherifard, Reshma Ramachandran, Joseph S. Ross
原始摘要（英文原文）· Original abstract
This cross-sectional study examines the time to market launch for recently approved therapeutics likely eligible for 2 new mandatory service and delivery models in most-favored-nation countries following US launch.